Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benedic Ippolito

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
JAMA Health Forum|August 15, 2025
The Future of Medicare Advantage-Assessing Current Debates and the Likelihood of Near-Term ReformsBenedic Ippolito
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2021
Branded Price Variation in the United States Drug Market, 2010 to 2019Joseph Levy, Benedic Ippolito
Health Affairs Scholar|May 12, 2025
Medicare at a crossroads: A conversation with Dr. Mark McClellan on program reforms and the growth of Medicare AdvantageMark McClellan, Benedic Ippolito
Health Affairs (Project Hope)|April 5, 2017
Mystery Of The Chargemaster: Examining The Role Of Hospital List Prices In What Patients Actually PayMichael Batty, Benedic Ippolito
JAMA Internal Medicine|October 5, 2018
Reduced Opioid Marketing Could Limit Prescribing Information for PhysiciansBenedic Ippolito, Stan Veuger
Health Affairs (Project Hope)|August 15, 2024
Expanding Medicare Coverage Of Anti-Obesity Medicines Could Increase Annual Spending By $3.1 Billion To $6.1 BillionBenedic Ippolito, Joseph F Levy
Health Affairs (Project Hope)|November 4, 2024
Expected Out-Of-Pocket Costs: Comparing Medicare Advantage With Fee-For-Service MedicareBenedic Ippolito, Erin Trish, Boris Vabson
Health Affairs (Project Hope)|July 26, 2018
Unlike Medical Spending, Medical Bills In Collections Decrease With Patients' AgeMichael Batty, Christa Gibbs, Benedic Ippolito
JAMA Health Forum|October 10, 2025
Most-Favored-Nation Drug Pricing-How Courts Could Shape Future Health RegulationNicholas Bagley, Craig Garthwaite, Benedic Ippolito
Health Affairs Scholar|February 2, 2026
Contextualizing new estimates of coding intensity in Medicare advantage and opportunities for further researchLoren Adler, Yevgeniy Feyman, Benedic Ippolito
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
JAMA Health Forum|August 15, 2025
The Future of Medicare Advantage-Assessing Current Debates and the Likelihood of Near-Term ReformsBenedic Ippolito
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|August 28, 2021
Branded Price Variation in the United States Drug Market, 2010 to 2019Joseph Levy, Benedic Ippolito
Health Affairs Scholar|May 12, 2025
Medicare at a crossroads: A conversation with Dr. Mark McClellan on program reforms and the growth of Medicare AdvantageMark McClellan, Benedic Ippolito
Health Affairs (Project Hope)|April 5, 2017
Mystery Of The Chargemaster: Examining The Role Of Hospital List Prices In What Patients Actually PayMichael Batty, Benedic Ippolito
JAMA Internal Medicine|October 5, 2018
Reduced Opioid Marketing Could Limit Prescribing Information for PhysiciansBenedic Ippolito, Stan Veuger
Health Affairs (Project Hope)|August 15, 2024
Expanding Medicare Coverage Of Anti-Obesity Medicines Could Increase Annual Spending By $3.1 Billion To $6.1 BillionBenedic Ippolito, Joseph F Levy
Health Affairs (Project Hope)|November 4, 2024
Expected Out-Of-Pocket Costs: Comparing Medicare Advantage With Fee-For-Service MedicareBenedic Ippolito, Erin Trish, Boris Vabson
Health Affairs (Project Hope)|July 26, 2018
Unlike Medical Spending, Medical Bills In Collections Decrease With Patients' AgeMichael Batty, Christa Gibbs, Benedic Ippolito
JAMA Health Forum|October 10, 2025
Most-Favored-Nation Drug Pricing-How Courts Could Shape Future Health RegulationNicholas Bagley, Craig Garthwaite, Benedic Ippolito
Health Affairs Scholar|February 2, 2026
Contextualizing new estimates of coding intensity in Medicare advantage and opportunities for further researchLoren Adler, Yevgeniy Feyman, Benedic Ippolito
Pageof 2